Park Avenue Securities’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.33M | Buy |
49,581
+3,499
| +8% | +$376K | 0.05% | 267 |
|
|
2025
Q1 | $4.65M | Buy |
46,082
+33,213
| +258% | +$3.35M | 0.06% | 215 |
|
|
2024
Q4 | $1.15M | Buy |
12,869
+1,381
| +12% | +$123K | 0.01% | 689 |
|
|
2024
Q3 | $963K | Sell |
11,488
-136
| -1% | -$11.4K | 0.01% | 706 |
|
|
2024
Q2 | $895K | Sell |
11,624
-811
| -7% | -$62.4K | 0.01% | 716 |
|
|
2024
Q1 | $852K | Buy |
12,435
+1,413
| +13% | +$96.8K | 0.01% | 737 |
|
|
2023
Q4 | $637K | Buy |
11,022
+380
| +4% | +$22K | 0.01% | 811 |
|
|
2023
Q3 | $562K | Buy |
+10,642
| New | +$562K | 0.01% | 794 |
|
|
2023
Q1 | – | Sell |
-8,515
| Closed | -$394K | – | 757 |
|
|
2022
Q4 | $394K | Buy |
8,515
+2,454
| +40% | +$114K | 0.01% | 868 |
|
|
2022
Q3 | $235K | Sell |
6,061
-697
| -10% | -$27K | ﹤0.01% | 1007 |
|
|
2022
Q2 | $252K | Buy |
6,758
+1,933
| +40% | +$72.1K | ﹤0.01% | 985 |
|
|
2022
Q1 | $214K | Buy |
+4,825
| New | +$214K | ﹤0.01% | 1067 |
|
|
2021
Q4 | – | Sell |
-4,629
| Closed | -$201K | – | 1103 |
|
|
2021
Q3 | $201K | Buy |
+4,629
| New | +$201K | ﹤0.01% | 1000 |
|
|
2020
Q4 | – | Sell |
-10,603
| Closed | -$405K | – | 846 |
|
|
2020
Q3 | $405K | Buy |
10,603
+3,354
| +46% | +$128K | 0.01% | 480 |
|
|
2020
Q2 | $255K | Buy |
+7,249
| New | +$255K | 0.01% | 561 |
|
|
2020
Q1 | – | Sell |
-4,732
| Closed | -$214K | – | 331 |
|
|
2019
Q4 | $214K | Buy |
+4,732
| New | +$214K | 0.01% | 558 |
|